Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Harnessing prostaglandin E2 signaling to ameliorate autoimmunity

Trends in Immunology(2023)10.1016/j.it.2023.01.004Source: DataRank Database

Harnessing prostaglandin E2 signaling to ameliorate autoimmunity is a research paper published in Trends in Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 39 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access39 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 7.39)OA: greenTopics (25)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Amanda C. Doran ORCID,Maureen Gannon ORCID,Juliann B. Burkett

Live enrichment

PubMed:36707339 PMC:PMC9975049 OpenAlex:https://openalex.org/W4318019502

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: 5T32 DK7563-30

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: R01DK120626

Department of Veterans Affairs

Grant: BX005399

National Heart Lung and Blood Institute Division of Intramural Research

Grant: HL159487

BLRD VA

Grant: I01 BX005399

NHLBI NIH HHS

Grant: R01 HL159487

NIDDK NIH HHS

Grant: T32 DK007563

Vanderbilt University

National Heart, Lung, and Blood Institute

National Institutes of Health

FWCI

7.39

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC9975049/pdf/nihms-1868711.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1471490623000042?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1471490623000042?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9975049

Fields of Study

Inflammatory mediators and NSAID effectsNF-κB Signaling PathwaysCytokine Signaling Pathways and Interactions

MeSH Terms

Autoimmune DiseasesHumansDinoprostoneSignal TransductionAutoimmunityT-Lymphocyte Subsets

Keywords

AutoimmunityProinflammatory cytokineImmunologyLipid signalingMediatorInflammationContext (archaeology)BiologySignal transductionImmune systemCell biologyMacrophageT cellsAnti-inflammatoryProinflammatoryPge(2)

Sustainable Development Goals

SDG 0: Good health and well-being

Harnessing prostaglandin E2 signaling to ameliorate autoimmunity

FAIR Checklist

Authors (3)

Funding (10 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)